adenosine monophosphate has been researched along with Malignant Melanoma in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
Authors | Studies |
---|---|
Alomari, M; Belov, L; Christopherson, RI; Fatima, N; Shen, Y | 1 |
Chen, W; Fan, N; Song, Y; Sun, Y; Wang, S; Wang, Y; Yan, L | 1 |
Ascierto, PA; Azzaro, R; Capone, M; Del Gaudio, P; Madonna, G; Monti, MC; Morello, S; Morretta, E; Simeone, E; Sorrentino, A; Turiello, R | 1 |
Dai, C; Dai, S; Su, KH; Tang, Z; Xu, M | 1 |
Ascierto, PA; Capone, M; Giannarelli, D; Grimaldi, AM; Madonna, G; Mallardo, D; Morello, S; Pinto, A; Sorrentino, C | 1 |
Drake, WP; Kopyta, LP; Levy, CC; Mardiney, MR | 1 |
Katakkar, SB; Khaliq, A; LePage, GA; Naik, SR | 1 |
7 other study(ies) available for adenosine monophosphate and Malignant Melanoma
Article | Year |
---|---|
Adenylated proteins in mouse B16-F10 melanoma cells cluster in functional categories: a new paradigm for cellular regulation?
Topics: Adenosine Monophosphate; Animals; Mammals; Melanoma; Mice; Protein Processing, Post-Translational | 2022 |
Itraconazole-Induced the Activation of Adenosine 5'-Monophosphate (Amp)-Activated Protein Kinase Inhibits Tumor Growth of Melanoma via Inhibiting ERK Signaling.
Topics: Adenosine; Adenosine Monophosphate; AMP-Activated Protein Kinases; Cell Line, Tumor; Cell Proliferation; Humans; Itraconazole; MAP Kinase Signaling System; Melanoma | 2022 |
Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; B7-H1 Antigen; GPI-Linked Proteins; Humans; Lymphocytes; Melanoma; Nivolumab; Pilot Projects; Retrospective Studies | 2022 |
Heat Shock Factor 1 Is a Direct Antagonist of AMP-Activated Protein Kinase.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Adiposity; AMP-Activated Protein Kinases; Animals; Binding Sites; Cell Proliferation; Cholesterol; Energy Metabolism; Heat Shock Transcription Factors; HEK293 Cells; HeLa Cells; Humans; Lipogenesis; Melanoma; Mice, 129 Strain; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Phosphorylation; Protein Conformation; Protein Stability; Signal Transduction; Skin Neoplasms; Structure-Activity Relationship | 2019 |
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab.
Topics: 5'-Nucleotidase; Adenosine Monophosphate; Antibodies, Monoclonal; Biomarkers, Tumor; Disease-Free Survival; Female; GPI-Linked Proteins; Humans; Kaplan-Meier Estimate; Male; Melanoma; Middle Aged; Nivolumab; Prognosis; Solubility; Survival Analysis; Treatment Outcome | 2017 |
Alterations in ribonuclease activities in the plasma, spleen, and thymus of tumor-bearing mice.
Topics: Adenocarcinoma; Adenosine Monophosphate; Animals; Cell Line; Cytidine Monophosphate; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Experimental; Ribonucleases; Sarcoma, Experimental; Spleen; Thymus Gland; Transplantation, Homologous; Uridine Monophosphate | 1975 |
9-beta-D-arabinofuranosyladenine 5'-phosphate metabolism and excretion in humans.
Topics: Adenocarcinoma; Adenosine Monophosphate; Aged; Carcinoma; Female; Gastrointestinal Neoplasms; Humans; Injections, Intravenous; Male; Melanoma; Middle Aged; Neoplasms; Time Factors; Vidarabine | 1975 |